NPLOC4, also known as NPL4, is uncharacterized in HCC but has been revealed as an important oncogene in bladder cancer (Lu et al., 2019) and a critical target of the anticancer drug disulfiram (Skrott et al., 2017; Pan et al., 2021). This evidence concerns the gene NPLOC4 and urinary bladder cancer.